Almirall: Sustained performance of key growth drivers and excellent progress on pipeline in H1 despite negative impact of COVID-19

BARCELONA, Spain, July 27, 2020 /PRNewswire/ -- Key growth drivers continue to show positive results. Ilumetri® performed strongly despite a decrease in new patient initiations during the COVID-19 pandemic, while Skilarence® results matched expectations, with flat sales excluding...

from PR Newswire: https://ift.tt/3hIOchJ